Home » Authors » Nuala Moran

Articles by Nuala Moran

Ark IPO Aims For £40M, Looks To End UK Public Offering Dry Spell

April 10, 2002

RiboTargets Signs With ICR To Develop Inhibitors Of HSP90

April 10, 2002

Ark IPO Aims For £40M, Looks To End UK Public Offering Dry Spell

April 10, 2002

Celltech Signs Drug Conjugate Deal With Seattle Genetics

April 3, 2002

Astex, Aventis Collaborate On Drug-Metabolizing Enzymes

April 3, 2002

British Biotech Receives FDA Approval For BB-10153 Trial

April 3, 2002

Protherics Releases Positive Data From Hypertension Trial

April 3, 2002

Celltech Signs Drug Conjugate Deal With Seattle Genetics

April 3, 2002

Protherics Releases Positive Data From Hypertension Trial

April 3, 2002

Astex, Aventis Collaborate On Drug-Metabolizing Enzymes

April 3, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...